{
    "id": 14650,
    "fullName": "CD79B Y197N",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "CD79B Y197N (corresponds to Y196N in the canonical isoform) lies within the ITAM domain of the Cd79b protein (UniProt.org). Y197N has been identified in the scientific literature (PMID: 28803429), but has not been biochemically characterized and therefore, its effect on Cd79b protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 11348,
                    "pubMedId": 28803429,
                    "title": "Patients with primary breast and primary female genital tract diffuse large B cell lymphoma have a high frequency of MYD88 and CD79B mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28803429"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 974,
        "geneSymbol": "CD79B",
        "terms": [
            "CD79B",
            "AGM6",
            "B29",
            "IGB"
        ]
    },
    "variant": "Y197N",
    "createDate": "12/02/2015",
    "updateDate": "10/09/2019",
    "referenceTranscriptCoordinates": {
        "id": 175967,
        "transcript": "NM_001039933",
        "gDna": "chr17:g.63929439A>T",
        "cDna": "c.589T>A",
        "protein": "p.Y197N",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3703,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a non-Hodgkin lymphoma (NHL) patient derived xenograft (PDX) model co-harboring CD79B Y197N and MYD88 L265P demonstrated sensitivity to Ibruvica (ibrutinib) while an NHL patient derived xenograft (PDX) model harboring only MYD88 L265P did not respond to Ibruvica (ibrutinib) (ASH 57th Annual Meeting, 2015, abstract #2759).",
            "molecularProfile": {
                "id": 14907,
                "profileName": "CD79B Y197N MYD88 L265P"
            },
            "therapy": {
                "id": 768,
                "therapyName": "Ibrutinib",
                "synonyms": null
            },
            "indication": {
                "id": 60060,
                "name": "non-Hodgkin lymphoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4013,
                    "pubMedId": null,
                    "title": "Biomarker Predictive Ibrutinib Response Using Profiled ABC-DLBCL Patient Derived Xenografts",
                    "url": "https://ash.confex.com/ash/2015/webprogram/Paper81154.html"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 14906,
            "profileName": "CD79B Y197N",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 14907,
            "profileName": "CD79B Y197N MYD88 L265P",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 175967,
            "transcript": "NM_001039933",
            "gDna": "chr17:g.63929439A>T",
            "cDna": "c.589T>A",
            "protein": "p.Y197N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}